Tradestie Institutional Equity Comparison Engine

CON vs GRDN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CON Overall Edge

CON Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Concentra Group Holdings Parent, Inc. (CON) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CON trades at 22.0x Forward P/E with 17.2% operating margin (+8.6% YoY revenue) versus GRDN at 31.3x Forward P/E and 6.5% operating margin (-1.7% YoY). In options structure, CON sits in BREAKOUT (95th %ile IV; Dealer Gamma Walls on Pro) against GRDN sits in SURGE (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CON
CON 22.0x vs GRDN 31.3x Fwd P/E
Growth & Margin Winner CON
Op Margin 17.2% vs 6.5% ยท YoY +8.6% vs -1.7%
Momentum & Technical Winner CON
1Y +117.6% vs +70.4% ยท 52W Pos 91% vs 84%
Options & Structure Winner CON
BREAKOUT (95th %ile IV) vs SURGE (7th %ile IV)
CON NYSE
Concentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, Nec
$41.84
+0.94% 1D
Market Cap $5.2B
1M Return +4.68%
1Y Return +117.58%
Forward P/E 22.0x
Unified AI Score
43.5 / 100 HOLD
Tech 31.0 Fund 47.0 Flow 69.0 Mom 41.1
GRDN NYSE
Guardian Pharmacy Services, Inc.
Retail-Drug Stores And Proprietary Stores
$46.94
+0.58% 1D
Market Cap $3.0B
1M Return +18.57%
1Y Return +70.38%
Forward P/E 31.3x
Unified AI Score
35.9 / 100 SELL
Tech 8.0 Fund 35.0 Flow 56.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CON +117.58% GRDN +70.38% Spread: +47.2 pp (CON Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CON Revenue GRDN Revenue CON Op. Margin GRDN Op. Margin Margin Edge
FY2022 $1.72B N/A 15.0% N/A CON
FY2023 $1.84B N/A 15.6% N/A CON
FY2024 $1.90B $1.23B 16.0% -5.1% CON
FY2025 $2.16B $1.45B 15.4% 5.0% CON

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CON (10) vs GRDN (0)
Institutional Metric CON GRDN Criterion Row Winner
Market Capitalization Scale $5.2B $3.0B Larger Scale CON
Trailing P/E Ratio Valuation 24.5x 39.9x Lower Multiple CON
Forward P/E Ratio Valuation 22.0x 31.3x Lower Multiple CON
Revenue Growth (YoY) Growth +8.6% -1.7% Higher Growth CON
Operating Margin (TTM) Profitability 17.2% 6.5% Higher Margin CON
Net Profit Margin Profitability 9.3% 5.1% Higher Margin CON
Return on Equity (ROE) Capital Efficiency 47.2% 32.0% Higher ROE CON
52-Week Range Position Momentum 91% ($19โ€“$44) 84% ($26โ€“$51) Stronger Trend CON
Beta / 30D Volatility Risk Regime 0.52ฮฒ ยท 38% Vol 0.51ฮฒ ยท 56% Vol Lower Realized Risk CON
Unified Institutional Score Composite Signal 43.5 / 100 (HOLD) 35.9 / 100 (SELL) Higher Composite CON

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CON vs GRDN Buy Guide
CON BREAKOUT
99d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 95th %ile
IV Regime Extreme (>80th %ile)
Live CON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GRDN SURGE
7d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live GRDN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CON nor GRDN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.